References
1. El Jammal, T., Jamilloux, Y., Gerfaud-Valentin, M., Valeyre, D., & Sève, P. (2020). Refractory Sarcoidosis: A Review. Therapeutics and clinical risk management , 16 , 323–345.
2. Winkelmann M, Rejeski K, Subklewe M, et al. Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma-A Diagnostic Challenge for Deauville Scoring on18F-FDG PET/CT Imaging. Diagnostics (Basel) . 2021;11(6):1009.
3. Joss N, Morris S, Young B, Geddes C. Granulomatous interstitial nephritis. Clin J Am Soc Nephrol . 2007;2(2):222-230.
4. Miedema J, Nunes H. Drug-induced sarcoidosis-like reactions.Curr Opin Pulm Med . 2021;27(5):439-447.
5. Reilly TB, Schuster DM, Starsiak MD, Kost CB, Halkar RK. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin’s lymphoma. Clin Nucl Med. 2007 Jul;32(7):569-71.
6. Vesely NC, Thomas RM, Rudnick E, Longo MI. Scar sarcoidosis following rituximab therapy. Dermatol Ther . 2020;33(6):e13693.
7. Galimberti F, Fernandez AP. Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?. Clin Exp Dermatol . 2016;41(4):413-416.
8. Pescitelli L, Emmi G, Tripo L, et al. Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: an uncommon adverse effect?. Eur J Dermatol . 2017;27(6):667-668.
9. Mouquet H, Musette P, Gougeon ML, et al. B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses. J Invest Dermatol . 2008;128(12):2859-2869.
10. Eisenberg R, Albert D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol . 2006;2(1):20-27.
11. London J, Grados A, Fermé C, et al. Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature.Medicine (Baltimore) . 2014;93(21):e121.
12. Krause JR, Sohn A. Coexisting sarcoidosis and occult mantle cell lymphoma. Proc (Bayl Univ Med Cent). 2020 Jul 21;33(4):651-652.